Sanofi (SNY) – 13Ds
-
Biotechnology Value Fund said Principia Biopharma Inc. (PRNB) proposed sale to Sanofi would be a 'suboptimal and, frankly, sad outcome'
-
Regeneron Pharmaceuticals (REGN) Higher as Sanofi Raises Stake in 20.5%
Back to SNY Stock Lookup